Energy & Commerce 340B Report Highlights Program Weaknesses

Jan 25, 2018 | 340B, Drugs, Hospitals

The Energy and Commerce committee released a report after two years of research into the operations and oversight of the 340B Drug Pricing Program. The report identifies several weaknesses in program administration and oversight. In this brief, we will provide an overview of the program, as well as the highlights from the committee’s report. Click to read more.

Insufficient State Data Collection Impedes National Medicaid Oversight

Jan 24, 2018 | Medicaid

In an effort to improve CMS oversight of the Medicaid program and combat improper payments, federal administrators designed an updated data repository system, known as Transformed Medicaid Statistical Information System (T-MSIS). Though concerns originally arose over program participation, efforts have recently shifted to address inconsistencies between state and national data reporting, which have hindered CMS’s ability to properly oversee the Medicaid program. Click to read more.

MedPAC Assesses PAC & Hospice Payment Adequacy

Jan 22, 2018 | Hospice, MedPAC, Post-Acute Care

MedPAC annually reviews Medicare payment policies and makes recommendations to Congress. In this brief, we highlight MedPAC’s assessment of Medicare payments for hospice services and post-acute care settings, including skilled nursing facilities, home health, inpatient rehabilitation facilities, and long-term care hospitals. Click to read more.